ZOSTAVAX (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ZOSTAVAX drug offered from Merck Sharp & Dohme Corp.. This Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Zoster Vaccine Live |
| SUBSTANCE NAME: | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN |
| TYPE: | VACCINE |
| PHARMA CLASS: | Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-05-25 |
| END MARKETING DATE: | 0000-00-00 |
ZOSTAVAX VACCINE Details:
| Item Description | ZOSTAVAX from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 19400([PFU]/.65mL) |
| START MARKETING DATE: | 2006-05-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-4963_e4ce356e-321e-4709-a664-9a7c196a3237 |
| PRODUCT NDC: | 0006-4963 |
| APPLICATION NUMBER: | BLA125123 |
Other VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:
